| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 136, 1043-1052, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
SL Cohn, AW Rademaker, HR Salwen, WA Franklin, F Gonzales-Crussi, ST Rosen and KD Bauer
Department of Pediatrics, Northwestern University, Chicago, Illinois.
Diploid DNA content, advanced stage, unfavorable histology, and N-myc amplification are all associated with aggressive disease and poor prognosis in childhood neuroblastoma. DNA diploidy is associated with advanced stage and unfavorable histology, but the relationships among ploidy, N-myc amplification, and proliferative activity are not known. To determine if DNA diploidy is associated with N-myc amplification, we studied 29 neuroblastomas with flow cytometric analysis and Southern blot analysis. Clinical and histologic features were also evaluated. Sixty percent of the N-myc-amplified tumors were diploid, compared to 26% of the neuroblastomas, which lacked N-myc amplification (P = 0.11). In our analysis of proliferative activity and N-myc amplification, a higher mean percentage of cells in S phase was seen in the N-myc- amplified tumors (13.4%) than in the unamplified tumors (10%), but again the result was not statistically significant (P = 0.14). Significant associations were seen between unfavorable histology and DNA diploidy (P = 0.05), and between unfavorable histology and high proliferative activity (P = 0.007). Our data suggest that biologic factors other than N-myc amplification play a role in determining the aggressiveness of at least some diploid neuroblastomas.
This article has been cited by other articles:
 |
|
 |
|
  R. E. George, W. B. London, S. L. Cohn, J. M. Maris, C. Kretschmar, L. Diller, G. M. Brodeur, R. P. Castleberry, and A. T. Look Hyperdiploidy Plus Nonamplified MYCN Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study J. Clin. Oncol., September 20, 2005; 23(27): 6466 - 6473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Weinstein, H. M. Katzenstein, and S. L. Cohn Advances in the Diagnosis and Treatment of Neuroblastoma Oncologist, June 1, 2003; 8(3): 278 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Bown Neuroblastoma tumour genetics: clinical and biological aspects J. Clin. Pathol., December 1, 2001; 54(12): 897 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lastowska, C. Cullinane, S. Variend, S. Cotterill, N. Bown, S. O'Neill, K. Mazzocco, P. Roberts, J. Nicholson, C. Ellershaw, et al. Comprehensive Genetic and Histopathologic Study Reveals Three Types of Neuroblastoma Tumors J. Clin. Oncol., June 15, 2001; 19(12): 3080 - 3090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Cohn Diagnosis and Classification of the Small Round-Cell Tumors of Childhood Am. J. Pathol., July 1, 1999; 155(1): 11 - 15. [Full Text] [PDF]
|
|
|
|
 |
|
 B.-F. Chen, M.-L. Chen, D.-C. Liang, H.-C. Liu, and S.-H. Chen The Relationship of N-myc Amplification and Apoptosis in Neuroblastoma International Journal of Surgical Pathology, January 1, 1999; 7(1): 19 - 25. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Chagnovich and S. L. Cohn Binding of a 40-kDa Protein to the N-myc 3'-Untranslated Region Correlates with Enhanced N-myc Expression in Human Neuroblastoma J. Biol. Chem., December 27, 1996; 271(52): 33580 - 33586. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
